Japan digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 8.2% during the forecast period. Japan has a significant growth in the dPCR and qPCR market owing to the increase in the prevalence of infectious disease and development in healthcare infrastructure. Among major global economies, Japan has the highest percentage of the geriatric population. Various cancers are more commonly found in the elderly age group. For instance, colon cancer accounts for more than 90% of individuals diagnosed over the age of 50. Similarly, stomach cancer accounts for about 60% of those diagnosed are over the age of 60. Cancer is one of the leading causes of death in Japan and the mortality rate is increasing since the last 30 years in the country as per the Japanese government. For instance, according to the World Health Organization (WHO), Japan recorded 883,395 new cancer cases in 2018. This leads to the adoption of dPCR and qPCr-based assays to detect mutations in a DNA region that is associated with many cancer types. 

The presence of some crucial players such as Takara Bio, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., and among others is estimated to be some of the major factors that are propelling the growth of the market. Further, strategic initiatives of players such as mergers, acquisitions, and product launches are also estimated to contribute towards the growth of the market. For instance, in January 2019, Abbott Laboratories announced that it has entered into an eight-year partnership agreement with the Japanese Red Cross Society (JRC). Under this agreement, Abbott is an exclusive supplier of serological instrumentation, tests, and consumables used for blood and plasma screening in Japan. The JRC screens approximately 5 million blood donations each year enabling ensure a safe supply of products needed for blood transfusions and plasma therapies. Abbott's broad portfolio of products is used to screen more than 60% of the world's blood and plasma supply. This development aids Abbott to strengthen its position and increase its revenue base in the Japanese market.

Research Methodology

The market study of the Japan dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Japan dPCR and qPCR Market Research and Analysis, By Technology
2. Japan dPCR and qPCR Market Research and Analysis, By Product
3. Japan dPCR and qPCR Market Research and Analysis, By Application

The Report covers:

• Comprehensive research methodology of the Japan dPCR and qPCR market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Japan dPCR and qPCR market.
• Insights about market determinants which are stimulating the Japan dPCR and qPCR market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.